<DOC>
	<DOCNO>NCT00580593</DOCNO>
	<brief_summary>The goal trial determine feasibility conduct randomize , double-blind , placebo-controlled trial nocturnal noninvasive positive pressure ventilation person amyotrophic lateral sclerosis force vital capacity great equal 50 percent .</brief_summary>
	<brief_title>Trial Early Noninvasive Ventilation Amyotrophic Lateral Sclerosis ( ALS )</brief_title>
	<detailed_description>Amyotrophic lateral sclerosis ( ALS ) untreatable neurodegenerative disorder characterize progressive loss motor neuron function . Respiratory failure common cause death person ALS . Treatment respiratory muscle weakness nocturnal noninvasive positive pressure ventilation ( NIPPV ) force vital capacity ( FVC ) less 50 percent—but prior development respiratory failure—has prolong survival observational study . Despite association NIPPV use survival , unknown whether early NIPPV treatment benefit people ALS . Also , placebo-controlled study NIPPV treatment people ALS conduct . The goal trial ass feasibility conduct prospective , randomize , double-blind , clinical trial NIPPV versus control ( sham ) NIPPV people ALS FVC great 50 percent , gain preliminary data outcome effect . In trial , investigator test follow hypothesis : ( 1 ) People ALS FVC great 50 percent tolerate active NIPPV control NIPPV , find control NIPPV believable treatment ; ( 2 ) Initiation active NIPPV people ALS FVC great 50 percent well clinical outcome respect measure quality life , rate pulmonary function decline , functional outcome ; ( 3 ) People ALS start active NIPPV early improve tolerance later respiratory weakness progress . These aim enable plan subsequent , large-scale definitive clinical trial early NIPPV ( FVC great 50 percent ) people ALS . If benefit early NIPPV confirm , new treatment may establish progressive , fatal disease .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Age &gt; 18 year old Probable possible ALS El Escorial criterion If childbearing potential , negative urine serum pregnancy test FVC &lt; 50 % predict age Previous pneumothorax Bullous emphysema Requirement oxygen Previous use positive pressure ventilation equipment ( continuous positive airway pressure , bilevel positive airway pressure ) Current involvement clinical treatment trial Any unstable medical condition think likely interfere participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>amyotrophic lateral sclerosis</keyword>
	<keyword>ALS</keyword>
	<keyword>nocturnal noninvasive positive pressure ventilation</keyword>
	<keyword>NIPPV</keyword>
	<keyword>force vital capacity</keyword>
	<keyword>FVC</keyword>
</DOC>